Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs) EQUITY
$97.68
neg -1.96
-1.97%
Today's Range: 97.62 - 99.35 | JNJ Avg Daily Volume: 7,585,000
Last Update: 06/29/15 - 4:01 PM EDT
Volume: 11,131,408
YTD Performance: -4.71%
Open: $98.98
Previous Close: $99.64
52 Week Range: $95.10 - $109.49
Oustanding Shares: 2,773,045,351
Market Cap: 274,864,255,191
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 2 2 3 3
Hold 7 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.07 2.07 2.06 2.06
Latest Dividend: 0.75
Latest Dividend Yield: 3.03%
Dividend Ex-Date: 05/21/15
Price Earnings Ratio: 17.73
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
17.73 17.70 26.65
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-0.50% -5.69% 50.02%
GROWTH 12 Mo 3 Yr CAGR
Revenue 4.20 0.14 0.05
Net Income 18.00 0.69 0.19
EPS 18.60 0.64 0.18
Earnings for JNJ:
EBITDA 24.85B
Revenue 74.33B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.71 $1.43 $6.14 $6.43
Number of Analysts 10 9 13 13
High Estimate $1.87 $1.57 $6.24 $6.60
Low Estimate $1.58 $1.25 $6.08 $6.21
Prior Year $1.66 $1.50 $5.97 $6.14
Growth Rate (Year over Year) 3.19% -4.44% 2.82% 4.74%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Roger Arnold

 | Jun 25, 2015 | 1:46 PM EDT

As health-care stocks rally, it's time for politicians to move on.

By

Jim Cramer

 | Jun 22, 2015 | 2:04 PM EDT

Don't rely on Europe; it's too out of sync with U.S.

By

Sebastian Silva

 | Jun 17, 2015 | 3:10 PM EDT

Jim Cramer recently shared his insight on some of the best potential takeover targets, and we're taking his lead and looking at how his picks...

By

Jim Cramer

 | Jun 16, 2015 | 2:10 PM EDT

All would produce higher prices for the acquirers.

By

David Katz

 | Jun 10, 2015 | 8:30 AM EDT

Focus on companies that benefit from an improving economy.

By

Jim Cramer

 | Jun 5, 2015 | 11:16 AM EDT

Greece and oil are positives, but employment was too strong.

By

Jim Cramer

 | Jun 4, 2015 | 6:36 AM EDT

The dollar is weakening. That's actually good for stocks. 

By

Jim Cramer

 | May 26, 2015 | 3:00 PM EDT

Picking up some high yielders might be worthwhile.

By

Jim Cramer

 | May 26, 2015 | 12:34 PM EDT

Jim Cramer reveals why his Action Alerts PLUS charitable trust portfolio is initiating coverage of Johnson & Johnson (JNJ) on Tuesday.

By

Jim Cramer

 | May 22, 2015 | 12:06 PM EDT

TheStreet's Jim Cramer answers your Twitter questions from the floor of the New York Stock Exchange.

Oof: Since their early June peaks, the Shanghai Composite is down 21.5%, the Shenzhen Comp...
Bad sign. we want futures down and down big. I know the trust will be a seller if we actu...

If we can hold above here look for a bounce. Don't forget the timing!!

...
First...no trigger no trade. This video is an example of how I come up with my price clust...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.